Industry: Pharmaceuticals, Biotechnology
Triton BioSystems is developing an innovative, targeted cancer therapeutic referred to as the TNTÔ System, which attacks adenocarcinoma tumors at the cellular level with negligible damage to surrounding healthy tissues. The Company has combined state-of-the-art technologies, including monoclonal antibodies, advanced nano-technology and magnetic energy to target and kill cancer cells. Triton BioSystems believes this will eliminate many of the side effects currently associated with conventional therapies. The Company is anticipating that it will begin human clinical trials in 2006. ( www.tritonbiosystems.com )
Triton BioSystems , Inc.
200 Turnpike Road
Chelmsford, Massachusetts 01824
USA
Tel: (978) 606-2900
Fax: (978) 250-4533